DK1974210T3 - Fremgangsmåde til diagnosticering af polycystisk nyresygdom - Google Patents

Fremgangsmåde til diagnosticering af polycystisk nyresygdom

Info

Publication number
DK1974210T3
DK1974210T3 DK07700227.7T DK07700227T DK1974210T3 DK 1974210 T3 DK1974210 T3 DK 1974210T3 DK 07700227 T DK07700227 T DK 07700227T DK 1974210 T3 DK1974210 T3 DK 1974210T3
Authority
DK
Denmark
Prior art keywords
kidney disease
polycystic kidney
procedure
diagnosing
diagnosing polycystic
Prior art date
Application number
DK07700227.7T
Other languages
English (en)
Inventor
Gerd Walz
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Application granted granted Critical
Publication of DK1974210T3 publication Critical patent/DK1974210T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Die Bonding (AREA)
  • Adhesive Tapes (AREA)
  • External Artificial Organs (AREA)
DK07700227.7T 2006-01-17 2007-01-17 Fremgangsmåde til diagnosticering af polycystisk nyresygdom DK1974210T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06000963A EP1808694A1 (en) 2006-01-17 2006-01-17 Method for diagnosing polycystic kidney disease
PCT/EP2007/000384 WO2007082733A1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease

Publications (1)

Publication Number Publication Date
DK1974210T3 true DK1974210T3 (da) 2011-02-21

Family

ID=35945115

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07700227.7T DK1974210T3 (da) 2006-01-17 2007-01-17 Fremgangsmåde til diagnosticering af polycystisk nyresygdom
DK10196792.5T DK2341344T3 (da) 2006-01-17 2007-01-17 Fremgangsmåde til diagnosticering af en polycystisk nyresygdom

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10196792.5T DK2341344T3 (da) 2006-01-17 2007-01-17 Fremgangsmåde til diagnosticering af en polycystisk nyresygdom

Country Status (8)

Country Link
US (1) US20110229895A1 (da)
EP (3) EP1808694A1 (da)
AT (1) ATE493649T1 (da)
DE (1) DE602007011566D1 (da)
DK (2) DK1974210T3 (da)
ES (2) ES2356481T3 (da)
PL (2) PL1974210T3 (da)
WO (1) WO2007082733A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101370826A (zh) * 2006-02-09 2009-02-18 诺瓦提斯公司 抗分泌型卷曲相关蛋白-4(sfrp-4)的抗体
EP3358354B1 (en) 2008-01-18 2020-07-15 President and Fellows of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
WO2009132815A1 (en) 2008-04-30 2009-11-05 Roche Diagnostics Gmbh Use of sfrp-3 in the assessment of heart failure
EP2394171A2 (de) * 2008-12-17 2011-12-14 mosaiques diagnostics and therapeutics AG Autosomal dominante polyzystische nierenerkrankung (adpkd)
NZ624614A (en) * 2009-11-07 2015-10-30 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102713632B (zh) * 2009-12-23 2015-10-07 希尔氏宠物营养品公司 用于诊断和治疗犬肾脏病症的组合物和方法
AU2011281007A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting kidney-associated diseases or conditions
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
CA2806293A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
EP2678687B1 (en) * 2011-02-24 2015-09-02 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a feline
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
EP4202441A3 (en) 2013-03-09 2023-07-26 Immunis.AI, Inc. Gene expression profile in macrophages for the diagnosis of cancer
WO2014197729A1 (en) 2013-06-05 2014-12-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
RU2017106891A (ru) 2014-08-04 2018-09-06 Джензим Корпорейшн Биомаркеры поликистозной болезни почек и пути их применения
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
US10456404B2 (en) 2015-03-13 2019-10-29 Indiana University Research And Technology Corporation Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
US10531837B1 (en) 2015-09-25 2020-01-14 Cerner Innovation, Inc. Predicting chronic kidney disease progression
JP6895963B2 (ja) 2015-11-18 2021-06-30 ジェンザイム・コーポレーション 多発性嚢胞腎のバイオマーカーおよびその使用
CN117337394A (zh) * 2021-05-17 2024-01-02 豪夫迈·罗氏有限公司 sFRP4作为血液生物标志物用于子宫腺肌病的非侵入性诊断
CN115060898B (zh) * 2021-07-01 2025-08-12 浙江大学 一种检测抗原肌球蛋白1-IgG抗体的试剂盒
EP4667628A1 (en) * 2024-06-19 2025-12-24 Albert-Ludwigs-Universität Freiburg Körperschaft des öffentlichen Rechts Synthetic lethality to treat autosomal dominant polycystic kidney disease (adpkd)
WO2025261741A1 (en) * 2024-06-19 2025-12-26 Albert-Ludwigs-Universitaet Freiburg Koerperschaft Des Oeffentlichen Rechts Synthetic lethality to treat autosomal dominant polycystic kidney disease (adpkd)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879885A1 (en) * 1997-05-23 1998-11-25 Smithkline Beecham Corporation A novel human gene similar to a secreted murine protein sFRP-1
US6638726B1 (en) * 2000-01-06 2003-10-28 Mount Sinai School Of Medicine Of New York University Screening methods for compounds useful in the treatment of polycystic kidney disease
AU2001280680A1 (en) * 2000-07-19 2002-01-30 Genzyme Corporation Phosphatonin-related gene and methods of use thereof
US20030143610A1 (en) * 2002-01-08 2003-07-31 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
AU2003259285A1 (en) * 2002-07-29 2004-02-16 Hmgene, Inc. Methods of identifying adipocyte specific genes, the genes identified, and their uses
WO2004076639A2 (en) * 2003-02-26 2004-09-10 Wyeth Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
BRPI0510367A (pt) * 2004-04-29 2007-11-06 Genzyme Corp métodos e composições para o tratamento de doenças policìsticas

Also Published As

Publication number Publication date
PL1974210T3 (pl) 2011-05-31
PL2341344T3 (pl) 2014-09-30
EP2341344B1 (en) 2014-04-30
EP1974210B1 (en) 2010-12-29
DK2341344T3 (da) 2014-06-30
ES2356481T3 (es) 2011-04-08
EP1974210A1 (en) 2008-10-01
DE602007011566D1 (en) 2011-02-10
ES2475540T3 (es) 2014-07-11
US20110229895A1 (en) 2011-09-22
ATE493649T1 (de) 2011-01-15
EP1808694A1 (en) 2007-07-18
EP2341344A1 (en) 2011-07-06
WO2007082733A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
DK2341344T3 (da) Fremgangsmåde til diagnosticering af en polycystisk nyresygdom
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
DK3489689T3 (da) Bestemmelse af neutrofil gelatinase-associeret lipocalin (NGAL) som diagnostisk markør for nyresygdomme
WO2008084331A3 (en) Biomarkers for renal disorders
NO20070949L (no) Transkriptomdiagnostikk i spytt
ATE533859T1 (de) MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN
WO2009038742A3 (en) Method for estimating risk of acute kidney injury
DE602006015151D1 (de) Vorrichtung für Kompressionsanastomose
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
BRPI0715126B8 (pt) métodos para avaliação do risco de intervenções cardíacas e usos à base de gdf-15
EA201100231A1 (ru) Диагностический анализ на основе антител
WO2008061149A3 (en) Methods and compositions for diagnosis and prognosis of renal artery stenosis
PL1910588T3 (pl) Sposób i układ do diagnozy elektrolizera oparty na analizie dopasowania krzywej i optymalizacji wydajności
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
WO2009078950A3 (en) Method of determing excretion of sodium and other analytes
DE602006016589D1 (de) Neue markierungsstrategien für den empfindlichen nachweis von analyten
WO2012178188A3 (en) Molecular diagnostic panel of eosinophilic gastrointestinal disorders
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
DE602008000683D1 (de) Immunassay-Verfahren, Reagenzienkit zur Erkennung einer Alkali-Phosphatase und Reagenzienkit für das Immunassay-Verfahren
BR112015014232A2 (pt) lesão renal aguda
WO2007003801A3 (fr) Methode et systeme pour la mesure et l'etude de l'encrassement d'un reacteur
WO2007032876A3 (en) Biomarkers associated with age-related macular degeneration